Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer’s Disease: Systematic Review of the ‘Real-World’ Evidence

Publisher： Karger

E-ISSN： 1421-9824|28|5|478-492

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.28, Iss.5, 2009-11, pp. : 478-492

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-06 ,pp. : 163-179

Karger

Access to resources Recommend Favorite

Galantamine: Additional Benefits to Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 1, 2000-09 ,pp. : 19-27

Karger

Access to resources Recommend Favorite

The Efficacy of Licensed-Indication Use of Donepezil and Memantine Monotherapies for Treating Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease: Systematic Review and Meta-Analysis

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-07 ,pp. : 212-227

Karger

Access to resources Recommend Favorite

An Observational Clinical Study of the Efficacy and Tolerability of Donepezil in the Treatment of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 15, Iss. 4, 2003-03 ,pp. : 189-198

Karger

Access to resources Recommend Favorite

Clinical Efficacy and Safety of Donepezil on Cognitive and Global Function in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 6, 2000-10 ,pp. : 299-313

Karger

Access to resources Recommend Favorite